What is the appropriate management of a non‑healing wound in a non‑diabetic patient with hypertension?

Management of Non-Healing Wound in Non-Diabetic Hypertensive Patient

For a non-healing wound in a non-diabetic hypertensive patient, prioritize aggressive assessment for peripheral arterial disease (PAD) and initiate sharp debridement with appropriate wound care, while optimizing blood pressure control to prevent microvascular complications that impair healing.

Initial Assessment and Vascular Evaluation

The most critical first step is determining whether arterial insufficiency is contributing to delayed healing. While the available guidelines focus heavily on diabetic wounds 1, 2, the principles of vascular assessment apply universally to non-healing wounds regardless of diabetes status 3.

Essential Vascular Studies

Perform the following bedside assessments immediately:

• Palpate foot pulses and obtain ankle-brachial index (ABI) with Doppler arterial waveforms 3
• ABI interpretation: Values 0.9-1.3 largely exclude PAD; <0.9 indicates arterial disease 3
• Toe pressure measurement: Values <30 mmHg or transcutaneous oxygen pressure (TcPO2) <25 mmHg indicate critical ischemia requiring urgent vascular imaging 3
• If ankle pressure <50 mmHg or ABI <0.5, consider urgent vascular imaging and revascularization 3

Critical caveat: In hypertensive patients, arterial calcification may falsely elevate ABI readings. If ABI >1.3, obtain toe pressures or TcPO2 for accurate assessment 3.

Core Wound Management Principles

Sharp Debridement (Primary Intervention)

Perform sharp debridement to remove necrotic tissue, slough, and surrounding callus 1, 2. This remains the gold standard regardless of diabetes status and should be done regularly based on clinical need 2. Sharp debridement is superior to autolytic, enzymatic, biosurgical, or ultrasonic methods 2.

Important exception: Avoid aggressive debridement if severe ischemia is present (ankle pressure <50 mmHg) until revascularization is achieved 3.

Wound Dressing Selection

Select dressings based on exudate control, comfort, and cost 1. Basic principles:

• Maintain moist wound environment with sterile, inert protective dressing 4
• Do not use antimicrobial/antiseptic dressings, silver-containing products, honey, collagen, or alginate dressings routinely—these show no benefit for healing 2
• Clean wound regularly with water or saline 4

Pressure Offloading

If the wound is on a weight-bearing surface, redistribute pressure away from the wound site 5. This principle applies to all chronic wounds, not just diabetic ulcers.

Hypertension-Specific Considerations

Hypertension creates a unique wound healing challenge through microangiopathy and impaired microcirculation 6, 7. Recent evidence suggests:

• Hypertensive patients may develop Martorell hypertensive ischemic leg ulcers—extremely painful ulcers typically on lateral lower leg 7
• Impaired microcirculation from chronic hypertension reduces tissue perfusion and oxygen delivery 6, 8
• Optimize blood pressure control to prevent further microvascular damage, but avoid hypotension that could worsen tissue perfusion 9

Red flags requiring specialist referral 7:

• Severe pain disproportionate to wound appearance
• Atypical location (lateral leg, not typical pressure points)
• Progression despite adequate wound care
• Violaceous or necrotic borders suggesting vasculitis

Infection Management

If infection is present (increased pain, erythema, purulence, warmth):

• Obtain deep tissue culture via biopsy or curettage after debridement—avoid swabs 5
• Start empiric antibiotics covering gram-positive cocci for mild-moderate infections 10
• Continue antibiotics until infection resolves, typically 1-2 weeks for soft tissue infection 10, 5
• Do not treat clinically uninfected wounds with antibiotics 5

Advanced Therapies (When Standard Care Fails)

If the wound fails to improve after 6 weeks of optimal management:

Consider Vascular Intervention

• Urgent vascular imaging if toe pressure <30 mmHg or TcPO2 <25 mmHg 3
• Goal: restore direct arterial flow to achieve toe pressure ≥30 mmHg or TcPO2 ≥25 mmHg 3

Adjunctive Therapies (Conditional Use)

Based on recent 2024 IWGDF guidelines 2:

• Negative pressure wound therapy (NPWT): Consider only for post-surgical wounds; do NOT use for non-surgical chronic wounds 2

  • In hypertensive patients with microangiopathy, if NPWT is used, consider lower pressure settings (-50 to -75 mmHg rather than standard -125 mmHg) to prevent ischemic necrosis 6

• Hyperbaric oxygen therapy: Consider for non-healing ischemic ulcers when standard care fails 1, 4

• Placental-derived products or autologous leucocyte/platelet/fibrin patch: May consider when standard care alone has failed 2

Therapies to AVOID

Strong evidence recommends against routine use of 2:

• Growth factors
• Bioengineered skin products
• Topical oxygen therapy
• Ultrasound, electromagnetic, or shockwave therapy
• Nutritional supplementation (vitamins, trace elements, protein) for wound healing

Clinical Algorithm

1. Assess vascular status (ABI, toe pressure, TcPO2)
2. Sharp debridement + basic moisture-retentive dressing
3. Offload pressure if weight-bearing location
4. Optimize blood pressure control
5. Treat infection if present (culture-directed antibiotics)
6. Reassess at 6 weeks: If no improvement → vascular imaging ± revascularization
7. Consider adjunctive therapies only after revascularization and continued failure of standard care

Common pitfall: Applying advanced wound products or NPWT to ischemic wounds without first addressing arterial insufficiency leads to treatment failure and potential tissue loss 3.